Bringing Innovation to Value-Based Care at Scale, With an Assist From Technology
June 23rd 2022The Institute of Value-Based Medicine® (IVBM), hosted by Tennessee Oncology, brought health care leaders together on April 21 in Nashville, Tennessee, to discuss oncology care delivery—and to see colleagues in person, some for the first time since 2020.
Read More
Leah Owens Explains Tennessee Oncology's Next Steps to Maintain Quality Care Post OCM
May 12th 2022After the Oncology Care Model (OCM) expires at the end of June, Tennessee Oncology will take what it learned from the model and apply it to commercial value-based care arrangements and potentially the next Medicare model, said Leah Owens, DNP, RN, executive director of care transformation at Tennessee Oncology.
Watch
Dr Davey Daniel on Barriers Limiting Genomic Testing Use in Lung Cancer
April 17th 2022Davey Daniel, MD, chief medical officer, OneOncology, speaks on the knowledge, infrastructure, and payer-related barriers that are limiting the use of genomic testing in the management of patients with lung cancer.
Watch
OneOncology’s Arrowsmith Looks Forward to Real-time Dynamics in Clinical Pathways
April 14th 2022Across OneOncology, says Edward Arrowsmith MD, MPH, clinical pathways offer a vehicle for physicians to agree on best practices and to implement them across the network. Early this year, Arrowsmith became medical director for Clinical Pathways, OneOncology.
Read More
Dr Gregory Vidal: Some Populations Continue to Face Barriers to Care Despite Virtual Options
March 13th 2022Minority, low-income, and elderly patients faced greater barriers to care even when it went virtual during the pandemic, according to Gregory Vidal, MD, PhD, medical oncologist specializing in breast cancer at West Cancer Center.
Watch
Dr Gregory Vidal Highlights RPM Technologies for His Patients With Breast Cancer
March 6th 2022During the COVID-19 pandemic, there has been a lot of experimentation with new technologies for remote patient monitoring (RPM) to improve adherence and survival, according to Gregory Vidal, MD, PhD, medical oncologist specializing in breast cancer at West Cancer Center.
Watch
PCOC Spotlight: How Community Oncology Is a Low-Cost, High-Quality Provider
December 20th 2021Jeffrey Patton, MD, is the CEO of OneOncology, a national partnership of independent community oncologists based in Nashville, Tennessee. He is also executive chairman of the board, Tennessee Oncology, and a member of the board, Community Oncology Alliance.
Read More
OneOncology Speakers Make Case for Community Setting in Research, Value Delivery
December 20th 2021Duncan Allen, MHA, introduced the audience to the OneR clinical research initiative, and Jeffrey Patton, MD, discussed how the hospital transparency law has bolstered the case for the value of community oncology.
Read More
Panel Discusses the Ongoing Evolution of Remote Patient Care
December 19th 2021The discussion, "Remote Patient Monitoring: Case Studies From the Front Lines,” explored real-world experiences with technology that has taken on greater heft as the COVID-19 pandemic continues to affect health care delivery.
Read More
With No Replacement for OCM on Horizon, Oncology Practices Ask: What Now?
November 22nd 2021The announcement of a "strategic refresh" for payment models under the Center for Medicare and Medicaid Innovation offered no details on what practices should expect when the Oncology Care Model (OCM) expires in 2022.
Read More
In Oncology Clinical Pathways, the Variability Isn’t With the Drugs
September 25th 2021Experts who took part in Patient-Centered Oncology Care® 2021 said when guidelines recommend high-cost targeted therapies or immunotherapies, the focus must turn to areas such as imaging, diagnostic tests, and other elements that contribute to the cost of care.
Read More
What's Next After OCM? Possibly a Gap and Something Mandatory, Experts Predict
September 25th 2021With the Oncology Care Model (OCM) slated to end in 2022, the successor model is still not in place. According to panelists, there is likely going to be a gap after OCM ends and the new model begins, but more importantly, practices should prepare for the new model to be mandatory.
Read More
Dr Jeff Patton Outlines How Community Oncology Is a Low-Cost, High-Quality Provider
September 24th 2021Having the option of receiving care in their community instead of a large hospital located hours away is not only a benefit for many patients, but research is showing community oncology practices are a low-cost, high-quality provider of care, explained Jeff Patton, MD, executive chairman of Tennessee Oncology and CEO of OneOncology.
Watch
Dr Daniel: “This Is Exactly How the Accelerated Approval Process Is Supposed to Work”
July 12th 2021Davey Daniel, MD, an oncologist with Tennessee Oncology in Chattanooga, spoke with The American Journal of Managed Care® (AJMC®) about the withdrawal of indications in small cell lung cancer (SCLC) for the PD-1 inhibitors pembrolizumab and nivolumab.
Read More
Dr Davey Daniel on Lower Cost of Care Seen in Clinical Trials for OCM Enrollees
June 4th 2021Davey Daniel, MD, hematology/medical oncology specialist, Tennessee Oncology, discusses findings of an abstract presented at ASCO 2021 showing a lower total cost of care paid by Medicare for episodes of care for patients in the Oncology Care Model (OCM) enrolled in clinical trials vs those receiving routine care.
Watch
Dr Edward Licitra on Aligning Patient, Physician Goals in Value-Based Cancer Care
April 9th 2021Edward Licitra, MD, PhD, medical oncologist, Astera Health Partners, discusses his thoughts on what value-based cancer care entails and how physicians can best align their goals with those of the patient and health plan.
Watch